The Covid-19 response in the USA has been much worse than in other countries like Canada and Jamaica, with 800,000 deaths so far. Former President Trump and his appointees as well as a lack of masking and testing contributed greatly to the poor response. The US healthcare system's costs also prevented some from seeking care. While vaccination has helped, the Delta variant has caused new waves and breakthrough cases show vaccination alone is not enough without other measures. Texas data shows the unvaccinated are over 10 times more likely to be infected or die from Covid. The Omicron variant is rising rapidly in parts of the US.
Presentation on Patient Safety Measurement for visitors from Sweden in 2007Noel Eldridge
This presentation was put together on the special topic of measurement when a group from Sweden was visiting the Dept of Veterans Affairs National Center for Patient Safety to learn about patient safety improvement programs underway there. I remember some of the people listening resisting my main point that so far there was no good way to measure PS outcomes, but some good ways to measure important outcomes that are potential precursors to patient safety problems (like not getting X-rays verified in a timely way).
Presentation on Patient Safety Measurement for visitors from Sweden in 2007Noel Eldridge
This presentation was put together on the special topic of measurement when a group from Sweden was visiting the Dept of Veterans Affairs National Center for Patient Safety to learn about patient safety improvement programs underway there. I remember some of the people listening resisting my main point that so far there was no good way to measure PS outcomes, but some good ways to measure important outcomes that are potential precursors to patient safety problems (like not getting X-rays verified in a timely way).
In early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination. After months of tireless effort, now that the vaccine has become a reality, we still find people hesitant to vaccinate.
n early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination.
Predicting coronavirus cases and questions need answeringJames Orr
Another weekend, and another attempt to make sense out of the Coronavirus Case data from states in the United States. Overall, cases per day remain flat (on plateau) with no decline in data. However, other indications suggest increasing irrelevant to use new cases per day for social policy decisions. Indication that new hospitalizations per day might be a better measure.
Trends in Opioid Misuse & Implications for Child Welfare inMatthew Lowe
The purpose of this research brief is to examine whether and how these national trends have affected New York families and children. We provide an overview of county-level trends in opioid misuse and child welfare caseloads and examine the relationship between the two. We identify counties that are particularly vulnerable and may benefit from additional resources to mitigate the impact of the opioid epidemic on families and children.
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptxNoel Eldridge
Patient Safety Presentation to 2007 Veterans Health Association NSQIP Meeting - includes information on wrong site surgery, retained surgical items, human factors, and other topics
In early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination. After months of tireless effort, now that the vaccine has become a reality, we still find people hesitant to vaccinate.
n early 2020, when the novel coronavirus began to spread around the world, it became increasingly clear that the most effective way to combat the raging pandemic would be for the majority of the population to develop immunity — whether through natural infection or vaccination.
Predicting coronavirus cases and questions need answeringJames Orr
Another weekend, and another attempt to make sense out of the Coronavirus Case data from states in the United States. Overall, cases per day remain flat (on plateau) with no decline in data. However, other indications suggest increasing irrelevant to use new cases per day for social policy decisions. Indication that new hospitalizations per day might be a better measure.
Trends in Opioid Misuse & Implications for Child Welfare inMatthew Lowe
The purpose of this research brief is to examine whether and how these national trends have affected New York families and children. We provide an overview of county-level trends in opioid misuse and child welfare caseloads and examine the relationship between the two. We identify counties that are particularly vulnerable and may benefit from additional resources to mitigate the impact of the opioid epidemic on families and children.
NSQIP 9-2007 Noel Eldridge FINAL 92407 for 925.pptxNoel Eldridge
Patient Safety Presentation to 2007 Veterans Health Association NSQIP Meeting - includes information on wrong site surgery, retained surgical items, human factors, and other topics
Patient safety disparities presentation from 2015 CDC National Conference on ...Noel Eldridge
My portion of a panel presentation with 3 other speakers at conference session "CC6" on August 25, 2015. Will update when all conference slides are posted to public. Current web link as of September 19, 2015 is: http://www.cdc.gov/nchs/events/2015nchs/program_tuesday.htm#c6
Disparities in Patient Safety - Presentation from 2013 Maryland Patient Safet...Noel Eldridge
Presentation provided at Conference in 2013 based on data from the Medicare Patient Safety Monitoring Sytems (MPSMS). Prepared and delivered a similar presentation in August 2015 updating this information and including published data from 2014. This newer presentation is on-line at http://www.slideshare.net/neldridge202/patient-safety-disparities-presentation-from-2015-cdc-national-conference-on-health-statistics
TIPS issue on the 2004 Joint Commission National Patient Safety Goals (NPSGs) - Starting with this issue, I authored or co-authored every annual issue on the NPSGs through 2010.
Presentation on the results to date of the Federal Partnership for Patients (...Noel Eldridge
This is the full set of the introductory slides and my slides covering the presentation. The sponsoring organization, Consumers Advancing Patient Safety (CAPS), which invited me to give this presentation, has posted a version with the audio and video together on-line at: http://iteleseminar.com/71861610
Crew Resource Management Slides - including Handoffs - from 2008 National Pat...Noel Eldridge
Presentation on Crew Resource Management and Team Training in the Department of Veterans Affairs. Dr. Dunn did most of the presentation, and I covered the handoffs portion. (Afterward someone from NPSF told me that this was the highest-rated breakout session at the conference.) One related video is on Youtube at: https://www.youtube.com/watch?v=aYZx1l8rkXA . A story on the software tool we developed for handoffs is at this website, see pages 12-13. http://www.va.gov/opa/publications/vanguard/09janfebVG.pdf
An article on the tool in the Joint Commission Journal is on-line at: http://www.ingentaconnect.com/content/jcaho/jcjqs/2010/00000036/00000002/art00003 Sorry it's not a full-text freebie. If you would like a pdf copy of it you can email me at neldridge202@yahoo.com.
Hand Hygiene Requirements and JCAHO National Patient Safety Goals in VHA 2003Noel Eldridge
Special TIPS (Topics in Patient Safety) newsletter issue on Hand Hygiene and the JCAHO (before rename to JC) NPSGs. The Summary of the CDC's guidance, if I remember correctly, is what was attached to the USH's memo to all VA facilities, if I remember correctly...
Hand Hygiene Presentation for February 2004 Veterans Health Administration "Q...Noel Eldridge
This presentation made clear the VHA policy to implement the CDC hand Hygiene Guideline a year before the VHA Directive was issued. A special memo and summary had been sent to VA Network Offices and Medical Center Directors from the Under Secretary for Health (Dr. Roswell). Will post the "TIPS" issue mentioned in slides. Memo has probably been lost in the mists of time. I have a video of this presentation (because it was broadcast on the VA's internal education system) on VHS and someday may get it on YouTube...
APIC "Futures Summit" Presentation April 2006Noel Eldridge
This was a presentation that I was invited to give at a "Summit" - Special Board meeting with invited guests - of the Association for Professionals in Infection Control. I remeember Rick Shannon also speaking and being impressed by his work, and CDC being there too. I was invited to talk about incentives for improving patient safety in VA, and I also added in slides about my frustration with the data on HAIs at that time.
Hand Hygiene Directive: Veterans Health Administration Directive 2005-002 ha...Noel Eldridge
This was the Department of Veterans Affairs first hand hygiene directive. It was based on the requirements of The Joint Commission (for Accredittion of Healthcare Organization's National Patient Safety Goal) requirement to implement the parts of the 2002 CDC Guideline for which there was strong evidence.
Improving Patient Safety Using Other-Than-"Evidence-Based" PracticesNoel Eldridge
Looks at PS and what has been done in other areas (like auto safety) to improve safety. Argues that action should be taken in the absence of surety that the action will work - based on prior rigorous scientific studies.
2001 Presentation to the NCVHS on VA's National Center for Patient SafetyNoel Eldridge
I think this was the first NCPS presentation I gave to an outside group of experts. The topic was the program itself and how it worked, and what it was trying to accomplish and what it was accomplishing. I had been in the job for about a year at this point. The meeting minutes are on-line at: http://www.ncvhs.hhs.gov/011212mn.htm One of the other presenters was Jim Battles of AHRQ. Now he and I have offices next door to each other at AHRQ (where I've been since 2010).
Large-Scale Disclosure Panel Presentation from 2008 Annual Meeting of America...Noel Eldridge
I was invited to present on a panel on the disclosure of adverse events at this annual meeting of the American Society for Bioethics and Humanities in Cleveland, and covered the VA policy at that time. I had been involved in the implementation of the policy and the writing of the policy documents, but not the core thinking behind the policy which was developed by a committee convened by the VA Center for Ethics in Health Care a few years earlier. Disclosure of adverse events is an area where VA has been a leader, but it has been challenging, especially in gray areas such as when it is unknown whether any patients were actually harmed by a breach in appropriate practices. The current VA policy is on-line at: http://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=2800 . Also on-line is a 2008 transcript when I participated as a speaker in a national VA call organized by the VA National Center for Ethics in Health Care: http://www.ethics.va.gov/docs/net/NET_Topic_20080226_Disclosure_of_Adverse_Events.doc
Presentation at 2007 Annual Meeting of VA Patient Safety Managers and OfficersNoel Eldridge
This presentation was for 150 or so Dept of VA Patient Safety managers with and for whom I worked at VA Central Office while they worked at the VA Medical Centers and Network offices. The main items of interest are the preliminary work that I was describing from the periphery of the then developing VA MRSA Prevention Program, which was quite successful and led by Dr. Rajiv Jain (and published in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1007474#t=abstract). Also of interest is the wide-ranging work that VA NCPS led on the follow up on an OIG report that identified problems in some of VA's operating rooms. Also of interest is slide 36 where I present some interesting data on VA's reduction in unadjusted inpatient mortality - this hasn't been widely publicized or published to my knowledge. The second to last slide refers to the fact that the day after the meeting I was going to the Grand Canyon and planning to hike to the bottom one day and out the next day. That turned out to be a great experience.
Presentation at 2007 Meeting of Indian Health Service in San DiegoNoel Eldridge
This is based on Jim Bagian's "Why Bother" (about patient safety) presentation. Jim was invited but had a conflict so I wen to the national meeting of the Indian Health Service. I think this was maybe a 75 minute presentation. I added some things to make it personal to me like the Jimi Hendrix Experience slide and slide 81 on the "tissue issue" in VA that I helped resolve during my work on hand hygiene improvement. The audience also seemed to like my closing slide.
April 2005 Medication Safety Presentation for IOM CommitteeNoel Eldridge
This presentation was made to the group that produced this report, The Future of Drug Safety: Promoting and Protecting the Health of the Public; which is online at: http://www.iom.edu/reports/2006/the-future-of-drug-safety-promoting-and-protecting-the-health-of-the-public.aspx. This was a big deal for me because it was the first time I presented to an IOM committee after having worked at the IOM's sister organization, the National Reseach Council, for 5 years, earlier in my career. I rmeember meeting my future boss at AHRQ, Dr. William Munier, for the first time at this meeting. Michael Valentino of the VA's Pharmacy Benefits Management Program was kind enough to come along with me that day in case I was asked drug questions that I couldn't answer.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Evaluation of antidepressant activity of clitoris ternatea in animals
COVID in the USA So Far
1. Covid in the USA So Far
Noel Eldridge, MS
For December 13, 2021 – Health Watch USA Presentation
This presentation is solely based on my personal opinions and does not represent the
opinions or view of any aspect of the US Government.
The information in this presentation is entirely from public sources.
1
2. Overall
• In summary the Covid-19 response in the USA has been very bad
• USA: 800,000 deaths in 334 million people = 1/418 people dead from Covid
• Canada: 30,000 deaths in 38 million people = 1/1,270 people dead from Covid
• Jamaica: 2,428 deaths in 3 million people = 1/1,235 people dead from Covid
• Why has the USA response been so bad?
• Former President Donald Trump and his horrible appointees
• He was and is the main reason for widespread vaccination and mask refusal, numerous other
reasons
• Lack of widespread and consistent indoor masking
• The US healthcare “system”
• People are sometimes reluctant to present for care due to fear of high costs
• Few organized testing programs, no easy or low-cost access to home tests, etc.
• Bad advice from good people at important times
• Telling people that they don’t need masks in first half of 2020
• Suggesting imminent pandemic end in June/July 2021 despite Delta variant cases rising
Source:
Stat News
2
3. The USA is Presently in its 6th Covid Wave
Source:
Covid Act Now
3
5. 5
3 waves in California and
Arizona, but not the same…
6. 6
2 waves in Virginia…
1 in Maryland?
New wave starting now in both?
7. The Crystal Ball is Covered with Mud…
paraphrasing Michael Osterholm
TOTAL
CASES
PER
100,000
TOTAL
DEATHS
PER
100,000
FULLY
VACCINATED
United States 49,929,628 15,048 796,175 240 61%
Mississippi › 519,115 17,443 10,326 347 48%
Alabama › 852,574 17,388 16,265 332 47%
New Jersey › 1,306,722 14,712 28,589 322 69%
Louisiana › 775,935 16,691 14,877 320 49%
Arizona › 1,318,580 18,116 23,040 317 56%
New York › 2,853,344 14,667 57,686 297 70%
Arkansas › 538,426 17,842 8,848 293 50%
Florida › 3,713,214 17,289 62,026 289 62%
Oklahoma › 681,346 17,219 11,384 288 52%
West Virginia › 308,204 17,197 5,107 285 71%
Source:
New York Times
7
8. Did this go down due to
widespread vaccination 65+?
Did this go up
due to Delta
“finding” the
unvaccinated
65+?
Did this go down due to
widespread vaccination of 65+
Source:
New York Times
8
10. 10
NOTE: With the Delta surge and
time passing (waning immunity?)
the rate among the vaccinated
stopped being close to zero
https://dshs.texas.gov/immunize/covid19/data/vaccination-status.aspx
11. Key Findings from Texas Study
• From September 4 through October 1, 2021:
• Unvaccinated people were 13 times more likely to become infected
with COVID-19 than fully vaccinated people.
• Unvaccinated people were 20 times more likely to experience COVID-
19-associated death than fully vaccinated people.
• Vaccination had a strong protective effect on infections and deaths among
people of all ages. The protective impact on infections was consistent across adult age groups and even greater in people ages 12 to
17 years. The protective impact on COVID-19 deaths, which was high for all age groups, varied more widely. In the September time frame,
unvaccinated people in their 40s were 55 times more likely to die from COVID-19 compared with fully vaccinated people of the same age.
Unvaccinated people aged 75 years and older were 12 times more likely to die than their vaccinated counterparts.
• Overall, regardless of vaccination status, people in Texas were four to five
times more likely to become infected with COVID-19 or suffer a COVID-19-
associated death while the Delta variant was prevalent in Texas (August
2021) compared with a period before the Delta variant became prevalent
(April 2021).
11
12. As of Monday,
Dec 13, 2021
• ”Researchers at the University
of Washington found that 13
percent of 217 positive
coronavirus case specimens
collected on Wednesday had
the mutation. That was up from
about 7 percent of samples they
had tested from the day before,
and 3 percent from the day
before that — in a region that
had its first identified cases only
two weeks ago.”
12
Source:
New York Times
14. A personal note:
Masks and UV
(since 2008)
• Link to Infection: Don’t Pass It On” Links:
• https://www.prevention.va.gov/flu/materials/posters/
respiratory-etiquette.asp
• Contact:
• Noel Eldridge - Facebook Messenger or LinkedIn
or neldridge202@gmail.com
14